Regulatory & Legal

A landmark defense contract for 100,000 night-vision devices in Europe signals a major leap in military tech and raises the bar for NATO interoperability.

A new campaign tackles undiagnosed kidney disease. But is it just public health, or a savvy strategy to reshape a multi-billion dollar market?

A regulatory filing reveals a key investor's move as Alkermes' $2.1B bid for Avadel and its blockbuster narcolepsy drug, LUMRYZ, nears its final act.

Kim Thinggaard's return as CEO of Enemærke & Petersen signals a strategic doubling-down on the trust-based partnership model he pioneered.

As federal aid dwindles, a major health system invests in an innovative food network, betting on infrastructure to combat hunger and chronic disease.

A new partnership aims to rapidly upskill the U.S. public sector workforce, providing critical cyber defenses against a surge in AI-powered attacks.

As climate disasters escalate, a major insurer is shifting from payouts to prevention. We decode this signal and its implications for the future of risk.

A $2.4B deal for AI's future. A hedge fund's strategic play. We decode the battle for Alphawave, the company powering the next tech revolution.

A hedge fund's 2.34% derivatives stake in Alphawave IP suggests a major acquisition by Qualcomm, highlighting a high-stakes battle for key chip IP.

A minor share sale by a US giant in a UK tech firm reveals the subtle art of institutional investing and the power of regulatory transparency.

Lightbeam's new NCQA prevalidation isn't just a certificate. It's a strategic move reshaping compliance, patient outcomes, and the health tech market.

The CRA's shift to online-only mail promises efficiency but creates new risks. Are Canadian businesses prepared for the compliance and security challenges?

The 2025 proxy season saw record director support as investors prioritized financials, yet dissent over executive pay signals a new battleground.

Balyasny Asset Management's complex derivative stake in JTC plc reveals the hidden strategies shaping a major takeover and the capital flows funding innovation.

With a new patent, this biotech targets the massive orthopedics market. But can its novel fibroblast therapy overcome steep financial and clinical hurdles?

USA Rare Earth is accelerating its timeline to mine critical minerals by two years. Can innovative tech and bold strategy break foreign supply chain dominance?

BlockQuarry unveils a sleek new website for its US-made miner, but can this digital pivot overcome steep financial hurdles and disrupt a crowded market?

Copper Quest diversifies from copper, acquiring a high-grade gold mine and adding 150+ years of mining expertise to its board and advisory team.

With a key FAA filing, Electra's hybrid-electric EL9 moves closer to reality, promising to bypass airports with 150-foot takeoffs and landings.

With new clinical data and recent FDA approval, IceCure Medical's tumor-freezing tech is paving a new, less-invasive path for breast cancer treatment.